Advertisement

Topics

Latest "Bard" News Stories

13:47 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "Bard" found in our extensive news archives from over 250 global news sources.

More Information about Bard on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Bard for you to read. Along with our medical data and news we also list Bard Clinical Trials, which are updated daily. BioPortfolio also has a large database of Bard Companies for you to search.

Showing "Bard" News Articles 1–25 of 280

Relevant

C.R. Bard Declares Quarterly Dividend

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's common stock. In connection with the pending merger with Becton, Dickinson & Company, the quarterly dividend will be payable on December ...


Bard acquires female external catheter company PureWick for $30mm

CR Bard Inc. acquired private non-invasive female urological drainage device maker PureWick Inc. for up to $30mm.

Extension of tender offer for Bard notes announced by BD

A tender offer for up to $1.1 billion in outstanding C. R. Bard notes has been extended again by Becton Dickinson from Oct.  -More- 


Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets

Merit's proposed asset acquisition is subject to the closing of BD’s proposed acquisition of Bard as well as other closing conditions.

$24B Becton Dickinson merger secures C.R. Bard shareholder approval

A merger deal between Becton Dickinson and C.R. Bard, valued at $24 billion, received approval from C.R.  -More- 

Tender offer for C.R. Bard notes extended again by BD

A tender offer for up to $1.1 billion worth of outstanding C. R. Bard notes was extended again by Becton Dickinson from Nov.  -More- 

Grant from CR Bard Supports Music Therapy at NJ Adult Day Center

Basking Ridge, NJ (PRWEB) July 21, 2017 The Visiting Nurse Association of Somerset Hills (VNA) has received a $5,000 grant from the C. R. Bard Foundation, Inc. to support the music therapy program offered at the Adult Day Center at Somerset Hills , a service available through the nonprof...

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15102017] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by C. R. Ba...

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by C. R. Ba...

Merit Medical - Becton And Bard Deal Looks Nice

Dividend Aristocrats In Focus Parts 25 And 26: Becton, Dickinson And C.R. Bard

C. R. Bard, Inc. Announces Second Quarter Results

  Life Sciences Jobs   ...

Dividend Aristocrats In Focus Parts 25 And 26: Becton Dickinson And C.R. Bard

C. R. Bard, Inc. Snags FDA Premarket Approval of The Lutonix 035 Drug Coated Balloon As The First And Only DCB

  Life Sciences Jobs   ...

C.R. Bard Shareholders Approve Proposed Merger With Becton, Dickinson and Company

  Life Sciences Jobs   ...

Bard Peripheral Vascular Named Arizona BioIndustry Association Of The Year

  Life Sciences Jobs   ...

Respected NYC Dermatologist Comments on New Research into Melanoma

Dr. Susan Bard, one of the top dermatologists and Mohs surgeons in Manhattan frequently sees people with skin cancer. Based on results from two international drug trials a combination of new treatments could halt the progression of melanoma, preventing it from spreading to other organs. New York, NY (PRWEB) September 26, 2017 Dr. Susan Bard, one of the top dermatologists and Mohs surgeons in Manh...

EU grants conditional nod for BD's $24B Bard acquisition

The European Commission gave Becton Dickinson antitrust approval for its $24 billion acquisition of C.R.  -More- 

Probably Relevant

Extension of exchange offer for Bard notes announced by BD

An exchange offer for a maximum of $1.1 billion worth of outstanding C.R.  -More- 

Timothy M. Ring and David F. Melcher to Join BD Board of Directors

FRANKLIN LAKES, N.J., Sept. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that two current directors of C.R. Bard, Inc. will join the BD board of directors following the completion of BD's pending acquisition of Bard. Timothy M. Ring, chairman and CEO of Bard, and David F. Melcher, president and CEO of the...

EU concessions for $24B Bard deal submitted by Becton Dickinson

The European Commission said concessions were submitted by Becton Dickinson to address EU antitrust issues concerning its pro -More- 

Berenberg senkt Ziel für Qiagen auf 31 Euro - 'Buy'

Die Privatbank Berenberg hat das Kursziel für Qiagen aufgrund der Euro-Stärke von 33 auf 31 Euro gesenkt, die Einstufung aber auf "Buy" belassen. Sein Kursziel in US-Dollar ließ Analyst Scott Bard...

Bard Peripheral Vascular Named Arizona Bioscience Company of the Year

Bard Peripheral Vascular, a division of C. R. Bard, will be honored for Advancing Lives and the Delivery of Health Care Worldwide at the 2017 AZBio Awards on Oct. 11, 2017 The Arizona Bioindustry Association (AZBio) will honor Bard Peripheral Vascular, a division of C. R. Bard, as the Arizona Bioscience Company of the Year the

The Journey from Passive to Active TMF with C.R. Bard, Inc. and Daiichi Sankyo, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 17, 2017) - Manual systems are unable to keep up with the pace and volume of modern clinical trials, making it increasingly difficult for clinical operations teams to manage end-to end processes and information in clinical studies. There are a variety of solutions being used by life sciences organizations to tackle this challenge. eTMFs are one of the most pop...

Traditional Chinese medicine: Eye of newt and toe of frog

‘Double, double toil and trouble; fire burn, and cauldron bubble’ chant the three witches in the cavern, lightening flashing outside, in Act 4, Scene 1 of Shakespeare’s Macbeth. It’s images like these, conjured up by the great bard himself, that I associate with traditional Chinese medicines and herbal remedies. The implied promise that if I take […] The post Traditi...


Quick Search
Advertisement
 

News Quicklinks